GVHD: biology matters
Tóm tắt
Acute graft-versus-host disease (GVHD) targets the crypts in the gastrointestinal (GI) tract that are responsible for the self-renewal of the intestinal mucosa. Recent advances in the identification and culture of intestinal stem cells have improved our understanding of the interactions between the microbiome and the immune system (both innate and adaptive) that are key to the pathophysiology of GVHD. The identification of serum biomarkers that best predict long-term GVHD outcomes derive from the GI tract and have focused attention on cellular elements that act as shields against GVHD as well as its targets. These biomarkers have illuminated new mechanisms of crypt biology and provided insights that should prove useful both in the design of clinical trials and as guides to GVHD prevention and treatment.
Tài liệu tham khảo
MacMillan, 2002, Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems, Biol Blood Marrow Transplant, 8, 387, 10.1053/bbmt.2002.v8.pm12171485
Clevers, 2013, The intestinal crypt, a prototype stem cell compartment, Cell, 154, 274, 10.1016/j.cell.2013.07.004
Cheng, 1974, Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types, Am J Anat, 141, 537, 10.1002/aja.1001410407
Barker, 2007, Identification of stem cells in small intestine and colon by marker gene Lgr5, Nature, 449, 1003, 10.1038/nature06196
Sato, 2009, Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche, Nature, 459, 262, 10.1038/nature07935
Sasaki, 2016, Reg4+ deep crypt secretory cells function as epithelial niche for Lgr5+ stem cells in colon, Proc Natl Acad Sci USA, 113, E5399, 10.1073/pnas.1607327113
Clevers, 2013, Paneth cells: maestros of the small intestinal crypts, Annu Rev Physiol, 75, 289, 10.1146/annurev-physiol-030212-183744
Cash, 2006, Symbiotic bacteria direct expression of an intestinal bactericidal lectin, Science, 313, 1126, 10.1126/science.1127119
Vaishnava, 2011, The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine, Science, 334, 255, 10.1126/science.1209791
Donaldson, 2016, Gut biogeography of the bacterial microbiota, Nat Rev Microbiol, 14, 20, 10.1038/nrmicro3552
Sato, 2011, Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts, Nature, 469, 415, 10.1038/nature09637
Yan, 2017, Non-equivalence of Wnt and R-spondin ligands during Lgr5+ intestinal stem-cell self-renewal, Nature, 545, 238, 10.1038/nature22313
van Es, 2005, Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells, Nature, 435, 959, 10.1038/nature03659
Sonnenberg, 2015, Innate lymphoid cells in the initiation, regulation and resolution of inflammation, Nat Med, 21, 698, 10.1038/nm.3892
Zheng, 2008, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens, Nat Med, 14, 282, 10.1038/nm1720
Sonnenberg, 2012, Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria, Science, 336, 1321, 10.1126/science.1222551
Lindemans, 2015, Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration, Nature, 528, 560, 10.1038/nature16460
Aparicio-Domingo, 2015, Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage, J Exp Med, 212, 1783, 10.1084/jem.20150318
Washington, 2009, Pathology of graft-versus-host disease in the gastrointestinal tract, Hum Pathol, 40, 909, 10.1016/j.humpath.2009.04.001
Naymagon, 2017, Acute graft-versus-host disease of the gut: considerations for the gastroenterologist, Nat Rev Gastroenterol Hepatol, 14, 711, 10.1038/nrgastro.2017.126
Levine, 2013, Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality, Blood, 122, 1505, 10.1182/blood-2013-02-485813
Zeiser, 2017, Acute graft-versus-host disease - biologic process, prevention, and therapy, N Engl J Med, 377, 2167, 10.1056/NEJMra1609337
Ferrara, 2017, Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis, J Clin Invest, 127, 2441, 10.1172/JCI90592
Reichenbach, 2015, The IL-33/ST2 axis augments effector T-cell responses during acute GVHD, Blood, 125, 3183, 10.1182/blood-2014-10-606830
Jenq, 2012, Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation, J Exp Med, 209, 903, 10.1084/jem.20112408
Shono, 2016, Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice, Sci Transl Med, 8, 339ra71, 10.1126/scitranslmed.aaf2311
Furusawa, 2013, Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells [published correction appears in Nature. 2014;506(7487):254], Nature, 504, 446, 10.1038/nature12721
Atarashi, 2013, Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota, Nature, 500, 232, 10.1038/nature12331
Mathewson, 2016, Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease, Nat Immunol, 17, 505, 10.1038/ni.3400
Zelante, 2013, Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22, Immunity, 39, 372, 10.1016/j.immuni.2013.08.003
Bruce, 2017, Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease, J Clin Invest, 127, 1813, 10.1172/JCI91816
Hayase, 2017, R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease, J Exp Med, 214, 3507, 10.1084/jem.20170418
Takashima, 2011, The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells, J Exp Med, 208, 285, 10.1084/jem.20101559
Glucksberg, 1974, Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors, Transplantation, 18, 295, 10.1097/00007890-197410000-00001
Rowlings, 1997, IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade, Br J Haematol, 97, 855, 10.1046/j.1365-2141.1997.1112925.x
Vander Lugt, 2013, ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death, N Engl J Med, 369, 529, 10.1056/NEJMoa1213299
Hartwell, 2017, An early-biomarker algorithm predicts lethal graft-versus-host disease and survival, JCI Insight, 2, e89798, 10.1172/jci.insight.89798